Brand Manager as a Service
Years of hands-on commercial life-science experience and capabilities as a scalable service. Fully end-to-end.
What we do
Plan. Create. Deliver.
One team covers the full loop, so nothing stalls at the handoff between strategy, execution and the field.
01
Plan
Brand plan and the insight behind it, built and localised with a focus on high-impact initiatives.
02
Create
Marketing materials in one place, omnichannel by default, approved through your own systems.
03
Deliver
The commercial calendar run end-to-end, from advisory boards to the sales force in the field.
How we help
Built around how you actually need help
Four situations we hear most from pharma and biotech teams in Switzerland.
Legacy & resource allocation
Keep your established brands moving
When priorities shift to new products or indications, your legacy brands keep earning revenue but stop getting attention — and budget is too tight to hire for it. We take over their day-to-day commercial management, from market analysis to omnichannel execution, so your in-house team can concentrate on what's strategic without your legacy brands losing share of voice.
Market entry
Capacity that scales with your launch
A Swiss launch needs different capacity at every stage — from pre-launch research 18–24 months before approval, through a roughly 180-day soft launch, to full commercial scaling in the first six months after approval. We staff the launch window at full strength in both marketing and the field, then release the capacity once it's no longer needed. You keep authorisation, regulatory and access; we take the commercial track. The timing matters: only 47% of EMA-approved medicines were fully available in Switzerland in 2024, down from 64% in 2018.
Source: Interpharma, Health Panorama 2025AI readiness
A seat at the AI model table
Physicians increasingly ask or spar with AI models about therapy decisions, guidelines or comparisons — and act on what they're shown. We generate unbranded scientific content, from guideline summaries to congress recaps, and place it where it gets crawled and read: your own channels, and earned placements on guideline platforms and medical-society sites.
In-field support
Field coverage, on demand
Coverage gaps from absences, or secondary segments that never get visited, rarely justify a new hire. We supply experienced KAMs for specific tasks and time periods, train and accompany your existing field force, and prepare territories through landscaping and opt-in generation.
Who we are
Two operators, not a bench of juniors
Rahul Habibur
- MSc in Pharma, ETH / Harvard Medical School
- MBA at IMD Lausanne
Naveed Khan
- MSc in Pharma, ETH / Harvard Medical School
Launches
Oncology: endometrial cancer launch, 2021 · Respiratory: launch of 2 novel asthma therapies, 2021 · Rare drug-induced brain bleedings: pre-launch, 2024
Therapy areas
Oncology: uncommon gynaecological tumours · Brand management in rheumatology · Pulmonary arterial hypertension, haematology & gastroenterology
Leadership
Leading teams, both line and matrix · P&L responsibility for budgets of up to CHF 6m
Companies
Our ask
Let's do a pilot
Pick one brand and one deliverable — a cycle campaign, a segmentation, or a region of field coverage. We fix a scope, and let our work speak for itself.